Sabra Health Care REIT, Inc. SBRA
20.47 USD +0.12 (+0.58%)
Nov 4, 2026, 9:41 AM EST
20.39 Day range 20.70
17.54 52-week range 22.77
- YTD
- +8.07%
- 1 year
- +13.84%
- Market cap
- 5.37B
- Revenue (ttm)
- 863.77M
- Profit margin
- 7.58%
- EPS (ttm)
- 0.27
- Shares out
- 255.46M
- P/E ratio
- 75.89
- Forward P/E
- 25.12
- Dividend
- 1.20 (6.29%)
- Ex-dividend date
- Aug 13, 2026
- YTD return
- +8.07%
- 1-year return
- +13.84%
- Volume
- 202.11K
- Avg volume
- 2.36M
- Open
- 20.51
- Previous close
- 20.35
- Day's range
- 20.39 – 20.70
- 52-week range
- 17.54 – 22.77
- Beta
- 0.64
- Analysts
- Buy
- Price target
- 22.36 (+9.2%)
- Earnings date
- Feb 11, 2027
YTD +1.20 (+6.27%)
Key statistics
- Enterprise value
- 7.43B
- PEG ratio
- 5.28
- Price / sales
- 6.02
- Price / book
- 1.82
- Dividend yield
- 6.08%
- Payout ratio
- 480.00%
- Revenue growth
- 25.30%
- Free cash flow
- 155.12M
- Total cash
- 246.31M
- Total debt
- 2.63B
- Return on equity
- 2.39%
- Short % of float
- 9.51%
- 50-day average
- 19.86
- 200-day average
- 19.97
Analyst view
Consensus: buy
Buy
Price target (mean) 22.36 +9.2% upside
Now 20.47
- Target (low)
- 19.00
- Target (mean)
- 22.36
- Target (high)
- 25.00
Ratings (0m) 16 6 buy · 10 hold · 0 sell
- Strong buy1
- Buy5
- Hold10
- Sell0
- Strong sell0
Next earnings
Feb 11, 2027
Expected Feb 11, 2027. Consensus EPS estimate 0.17667.
Financials — quick view
SBRA Revenue — quarterly 235.87M
SBRA Net income — quarterly -25.20M
SBRA EPS — quarterly -0.10
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2027 | Dec 30, 2026 | 0.1693 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | 0.1637 | 0.11 | -0.05 | -32.80% |
| Aug 3, 2026 | Jun 30, 2026 | 0.1711 | -0.10 | -0.27 | -158.45% |
| Apr 29, 2026 | Mar 31, 2026 | 0.1667 | 0.16 | -0.01 | -4.02% |
| Feb 12, 2026 | Dec 31, 2025 | 0.17 | 0.11 | -0.06 | -35.29% |
| Nov 5, 2025 | Sep 30, 2025 | 0.1834 | 0.094 | -0.09 | -48.75% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 13, 2026 | UBS | main | Neutral | Neutral |
| Oct 13, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Baird | main | Neutral | Neutral |
| Aug 6, 2026 | Raymond James | up | Underperform | Market Perform |
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Country
- United States
- Website
- sabrahealth.com
News
Sabra Health Care: 3 Key Takeaways for Long-Term Investors 
What Sabra Healthcare REIT (SBRA) Said on Its Q3 Earnings Call 
Sabra Health Care REIT, Inc. (SBRA) Q3 2026 Earnings Call Transcript 
Sabra Health Care REIT Q3 2026 Earnings Call Transcript 
Sabra Healthcare (SBRA) Tops Q3 FFO and Revenue Estimates 
Sabra Health Care REIT Raises FY2026 FFO Guidance from $1.53-$1.55 to $1.54-$1.55 vs $1.55 Est 
Sabra Health Care REIT Q3 FFO $0.39, Inline, Sales $249.565M Beat $232.392M Estimate 
Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance 
Senior Housing Demand Is Rising. Can These 4 REITs Turn It Into Bigger Dividends? 
Wells Fargo Maintains Overweight on Sabra Health Care REIT, Lowers Price Target to $21
Your note
Sign in to keep a note on SBRA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBAROSH CRAIG A | Director | Stock Award(Grant) | Aug 30, 2026 | 159,033 |
| COSTA MICHAEL LOURENCO | Chief Financial Officer | Stock Award(Grant) | Aug 30, 2026 | 470,870 |
| CUSACK CATHERINE | Director | Stock Award(Grant) | Aug 30, 2026 | 82,847 |
| FLORES JESSICA | Officer | Stock Award(Grant) | Aug 30, 2026 | 72,476 |
| FOSTER MICHAEL JEFFREY | Director | Stock Award(Grant) | Aug 30, 2026 | 125,246 |
| KATZMANN LYNNE S. | Director | Stock Award(Grant) | Aug 30, 2026 | 86,912 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.29% | 41,614,351 | 846.85M | Jun 29, 2026 |
| Principal Financial Group, Inc. | 9.33% | 23,836,388 | 485.07M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 9.14% | 23,352,373 | 475.22M | Jun 29, 2026 |
| State Street Corporation | 4.82% | 12,305,655 | 250.42M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.44% | 11,349,125 | 230.95M | Jun 29, 2026 |
| Geode Capital Management, LLC | 3.10% | 7,909,172 | 160.95M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund | 3.75% | 9,591,242 | 195.18M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 9,099,666 | 185.18M | Sep 29, 2026 |
| Principal Funds, Inc-Real Estate Securities Fund | 3.24% | 8,264,998 | 168.19M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.13% | 8,001,962 | 162.84M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.61% | 6,655,161 | 135.43M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.26% | 5,786,194 | 117.75M | Jun 29, 2026 |